IDNA:NYE-iShares Genomics Immunology and Healthcare ETF (USD)

ETF | Health |

Last Closing

USD 24.735

Change

+0.18 (+0.71)%

Market Cap

USD 0.14B

Volume

0.07M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-05 )

ETFs Containing IDNA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.50% 62% D 54% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.50% 62% D 54% F
Trailing 12 Months  
Capital Gain 26.52% 86% B+ 70% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 26.52% 86% B+ 70% C-
Trailing 5 Years  
Capital Gain -5.52% 48% F 46% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -5.52% 48% F 47% F
Average Annual (5 Year Horizon)  
Capital Gain -2.54% 5% F 23% F
Dividend Return -2.05% 5% F 14% F
Total Return 0.49% 53% F 12% F
Risk Return Profile  
Volatility (Standard Deviation) 35.06% 14% F 28% F
Risk Adjusted Return -5.84% 5% F 19% F
Market Capitalization 0.14B 60% D- 32% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.